Catalyst Pharmaceuticals Stock Filter Stocks by Fundamentals

CPRX Stock  USD 15.94  0.33  2.03%   
Catalyst Pharmaceuticals fundamentals help investors to digest information that contributes to Catalyst Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Catalyst Stock. The fundamental analysis module provides a way to measure Catalyst Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Catalyst Pharmaceuticals stock.
Price To Book Ratio is likely to drop to 4.68 in 2024.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Catalyst Price to Book Analysis

 2021 2022 2023 2024 (projected)
Total Stockholder Equity206.8M300.4M387.9M407.3M
Total Assets237.8M375.6M471.9M495.5M
More About Price to Book | All Equity Analysis

Catalyst Price to Book Driver Correlations

Understanding the fundamental principles of building solid financial models for Catalyst Pharmaceuticals is extremely important. It helps to project a fair market value of Catalyst Stock properly, considering its historical fundamentals such as Price to Book. Since Catalyst Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Catalyst Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Catalyst Pharmaceuticals' interrelated accounts and indicators.
1.0-0.790.30.80.980.910.910.790.90.480.470.930.840.860.99-0.50.680.890.750.510.81-0.870.1
1.0-0.790.320.810.980.910.90.790.90.50.480.930.830.860.99-0.490.690.890.750.510.81-0.860.08
-0.79-0.79-0.65-0.74-0.78-0.97-0.64-0.52-0.47-0.61-0.54-0.63-0.35-0.82-0.840.44-0.74-0.8-0.950.09-0.410.640.03
0.30.32-0.650.390.220.550.010.12-0.010.430.480.3-0.180.530.42-0.150.470.390.65-0.5-0.04-0.02-0.65
0.80.81-0.740.390.740.840.60.270.680.870.460.760.630.760.84-0.060.930.630.560.190.54-0.55-0.06
0.980.98-0.780.220.740.890.950.810.890.420.390.890.820.850.96-0.560.620.880.750.510.81-0.920.18
0.910.91-0.970.550.840.890.760.610.660.640.560.770.560.870.95-0.410.790.860.910.130.58-0.740.01
0.910.9-0.640.010.60.950.760.830.860.270.190.790.850.650.85-0.520.470.810.630.660.82-0.990.31
0.790.79-0.520.120.270.810.610.830.75-0.10.30.720.70.610.74-0.720.150.790.630.620.75-0.820.19
0.90.9-0.47-0.010.680.890.660.860.750.330.250.940.970.740.85-0.450.530.730.40.770.89-0.810.11
0.480.5-0.610.430.870.420.640.27-0.10.330.370.440.280.520.550.230.950.450.4-0.140.09-0.23-0.12
0.470.48-0.540.480.460.390.560.190.30.250.370.330.20.520.53-0.050.450.470.57-0.060.19-0.070.17
0.930.93-0.630.30.760.890.770.790.720.940.440.330.860.870.91-0.520.640.790.540.560.82-0.76-0.14
0.840.83-0.35-0.180.630.820.560.850.70.970.280.20.860.60.77-0.370.460.650.290.860.87-0.80.24
0.860.86-0.820.530.760.850.870.650.610.740.520.520.870.60.89-0.570.690.790.740.170.63-0.62-0.15
0.990.99-0.840.420.840.960.950.850.740.850.550.530.910.770.89-0.460.740.890.790.410.76-0.810.03
-0.5-0.490.44-0.15-0.06-0.56-0.41-0.52-0.72-0.450.23-0.05-0.52-0.37-0.57-0.46-0.03-0.54-0.49-0.23-0.480.57-0.01
0.680.69-0.740.470.930.620.790.470.150.530.950.450.640.460.690.74-0.030.660.540.020.27-0.44-0.08
0.890.89-0.80.390.630.880.860.810.790.730.450.470.790.650.790.89-0.540.660.80.360.52-0.80.14
0.750.75-0.950.650.560.750.910.630.630.40.40.570.540.290.740.79-0.490.540.8-0.080.39-0.630.02
0.510.510.09-0.50.190.510.130.660.620.77-0.14-0.060.560.860.170.41-0.230.020.36-0.080.73-0.610.35
0.810.81-0.41-0.040.540.810.580.820.750.890.090.190.820.870.630.76-0.480.270.520.390.73-0.780.08
-0.87-0.860.64-0.02-0.55-0.92-0.74-0.99-0.82-0.81-0.23-0.07-0.76-0.8-0.62-0.810.57-0.44-0.8-0.63-0.61-0.78-0.25
0.10.080.03-0.65-0.060.180.010.310.190.11-0.120.17-0.140.24-0.150.03-0.01-0.080.140.020.350.08-0.25
Click cells to compare fundamentals
Competition

Catalyst Price Book Value Ratio

Price Book Value Ratio

4.68

At this time, Catalyst Pharmaceuticals' Price Book Value Ratio is fairly stable compared to the past year.
Based on the latest financial disclosure, the price to book indicator of Catalyst Pharmaceuticals is roughly 0.0null. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Price to Book (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Price Exposure Probability Now

   

Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
All  Next Launch Module

Catalyst Fundamentals

About Catalyst Pharmaceuticals Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Catalyst Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Catalyst Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Catalyst Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Price To Book Ratio 4.93  4.68 

Catalyst Pharmaceuticals Investors Sentiment

The influence of Catalyst Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Catalyst. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Catalyst Pharmaceuticals' public news can be used to forecast risks associated with an investment in Catalyst. The trend in average sentiment can be used to explain how an investor holding Catalyst can time the market purely based on public headlines and social activities around Catalyst Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Catalyst Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Catalyst Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Catalyst Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Catalyst Pharmaceuticals.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Catalyst Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Catalyst Pharmaceuticals' short interest history, or implied volatility extrapolated from Catalyst Pharmaceuticals options trading.

Pair Trading with Catalyst Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Catalyst Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving against Catalyst Stock

  0.55CLVRW Clever Leaves HoldingsPairCorr
The ability to find closely correlated positions to Catalyst Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Catalyst Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Catalyst Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Catalyst Pharmaceuticals to buy it.
The correlation of Catalyst Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Catalyst Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Catalyst Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Catalyst Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Catalyst Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Catalyst Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Catalyst Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Catalyst Pharmaceuticals Stock:
Check out Catalyst Pharmaceuticals Piotroski F Score and Catalyst Pharmaceuticals Altman Z Score analysis.
For more information on how to buy Catalyst Stock please use our How to Invest in Catalyst Pharmaceuticals guide.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Catalyst Stock analysis

When running Catalyst Pharmaceuticals' price analysis, check to measure Catalyst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalyst Pharmaceuticals is operating at the current time. Most of Catalyst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Catalyst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Catalyst Pharmaceuticals' price. Additionally, you may evaluate how the addition of Catalyst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Is Catalyst Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Catalyst Pharmaceuticals. If investors know Catalyst will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Catalyst Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.346
Earnings Share
0.63
Revenue Per Share
3.747
Quarterly Revenue Growth
0.82
Return On Assets
0.1283
The market value of Catalyst Pharmaceuticals is measured differently than its book value, which is the value of Catalyst that is recorded on the company's balance sheet. Investors also form their own opinion of Catalyst Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Catalyst Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Catalyst Pharmaceuticals' market value can be influenced by many factors that don't directly affect Catalyst Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Catalyst Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Catalyst Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Catalyst Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.